IF: 13.903: Haifeng Dong (etc.), Engineered Exosome-Mediated Near-Infrared-II Region V2C Quantum Dot Delivery for Nucleus-Target Low-Temperature Photothermal Therapy

Author:     Release time:2019-09-20 17:59:38

IF: 13.903: Engineered Exosome-Mediated Near-Infrared-II Region V2C Quantum Dot Delivery for Nucleus-Target Low-Temperature Photothermal Therapy

Yu Cao, Tingting Wu, Kai Zhang, Xiangdan Meng, Wenhao Dai, Dongdong Wang, Haifeng Dong,* and Xueji Zhang*Engineered Exosome-Mediated Near-Infrared-II Region V2C Quantum Dot Delivery for Nucleus-Target Low-Temperature Photothermal Therapy, ACS NANO 2019, 13(2), 1499-1510


文章1-2.jpg


ABSTRACT: The limited penetration depth of photothermal agents (PTAs) active in the NIR-I biowindow and the thermoresistance caused by heat shock protein (HSP) signifificantly limit the therapeutic effiffifficiency of photothermal therapy (PTT).

To address the problem, we introduce a strategy of low-temperature nucleus-targeted PTT in the NIR-II region achieving effffective tumor killing by combining the vanadium carbide quantum dots (V2C QDs) PTA and an engineered exosomes (Ex) vector. The small flfluorescent V2C QDs with good photothermal effffect in the NIR-II region were modifified with TAT peptides and packaged into Ex with RGD modifification (V2C-TAT@Ex-RGD). The resulting nanoparticles (NPs) exhibited good biocompatibility, long circulation time, and endosomal escape ability, and they could target the cell and enter into the nucleus to realize low-temperature PTT with advanced tumor destruction effiffifficiency. The flfluorescent imaging,

photoacoustic imaging (PAI), and magnetic resonance imaging (MRI) capability of the NPs were also revealed. The low-temperature nucleus-targeted PTT in the NIR-II region provides more possibilities toward successful clinical application of PTT.


KEYWORDS: low-temperature PTT, nucleus target, exosomes, NIR-II biowindow


  • School of Chemistry and Biological Engineering, USTB
  • 30 Xueyuan Road, Haidian District, Beijing,100083